Inogen (NASDAQ:INGN) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.36) by 57.98 percent. This is a 37.5 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $81.721 million which missed the analyst consensus estimate of $85.050 million by 3.91 percent. This is a 2.05 percent increase over sales of $80.081 million the same period last year.